Danaher signals beyond the news: 26 signals from 3 sources
The latest Danaher signal on this page is from Aug 17, 2026 (Website changes): "Danaher published its second-quarter 2026 financial results, with all results presented as period-to-period comparisons." The busiest sources: Website changes (14), LinkedIn (10) and Web traffic (2).
Public (DHR)Appliances, Electrical, and Electronics Manufacturing10,000+ employeesdanaher.comLinkedIn
- Signals
- 26
- Sources
- 3
- Last 90 days
- 10
- Latest
- Aug 17, 2026
Other signals · latest 10
Latest Danaher signals by source
26 signals for Danaher across 3 sources.
Website changes · Funding news
Danaher published its second-quarter 2026 financial results, with all results presented as period-to-period comparisons.
Added press release: “Danaher Reports Second Quarter 2026 Results,” stating that all results reflect only continuing operations and period-to-period comparisons.
- Page
- /newsroom
Website changes · Executive change
Danaher appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026.
Added text states that the Board of Directors appointed Julie Sawyer Montgomery as President and Chief Executive Officer, effective October 1, 2026.
- Page
- /newsroom
Website changes · Team expansion
Danaher replaced its prior Sustainability Report link with a 2026 Sustainability Report, indicating a new annual sustainability disclosure.
The link changed from “Read our Sustainability Report” to “Read the 2026 Sustainability Report,” pointing to “Danaher_2026_Sustainability_Report_FINAL.pdf.”
- Page
- /
Website changes · Market data
Danaher added coverage of its 2026 Summit, highlighting takeaways from the event and reinforcing its focus on bioprocessing and science.
A new news item was added: “Top six takeaways from the 2026 Danaher Summit,” dated 06.15.26, alongside existing coverage of Danaher’s bioprocessing and science initiatives.
- Page
- /
Web traffic · Sustained growth
danaher.com shows sustained growth with 3 consecutive months of increases, up 33% overall to 369K.
- Monthly visits
- 368,959
- Month over month
- +24.3%
- 3-month change
- +33.5%
- Global rank
- 116,740
Web traffic · Sustained decline
danaher.com shows sustained decline with 3 consecutive months of decreases, down 30% overall to 230K.
- Monthly visits
- 229,789
- Month over month
- -5.5%
- 3-month change
- -29.6%
- Global rank
- 183,010
LinkedIn
Rare diseases are often overlooked and underfunded.
Rare diseases are often overlooked and underfunded. Patients endure pills, injections and surgeries without ever addressing the root cause. Even as next-generation sequencing and CRISPR unlock new possibilities, the path from discovery to delivery remains fragmented. The first gene editing therapies have shown...
- Likes
- 55
- Comments
- 1
- Tags
- Pharmaceuticals, Research & Development, Regulations, Logistics / Supply Chain
LinkedIn
Nature shows us that breakthroughs require dedication and growth.
Nature shows us that breakthroughs require dedication and growth. In 2025, that commitment united our teams, partners and customers to accelerate ideas into impact and make life better for patients everywhere. Now, we move into 2026 ready to keep improving at the #speedoflife. 📷 Nicolai Nielsen, Radiometer associate
- Likes
- 194
- Comments
- 3
- Tags
- Partnership, Patient Experience, Research & Development, Organizational Development
LinkedIn
More than 300 million people worldwide live with a rare disease, and 72% of those conditions stem from genetic mutations.
More than 300 million people worldwide live with a rare disease, and 72% of those conditions stem from genetic mutations. For many, treatment means managing symptoms for life. But what if science could move beyond treatment and toward cures? At Danaher, we help researchers accelerate breakthroughs in gene editing...
- Likes
- 133
- Tags
- Medical Research, Healthcare Technology, Pharmaceuticals, Product Development
LinkedIn
This year, biomarker breakthroughs accelerated the future of dementia detection.
This year, biomarker breakthroughs accelerated the future of dementia detection. #Alzheimers diagnostics are entering a new era of precision. In 2025, Beckman Coulter Diagnostics received FDA Breakthrough Device Designation for a plasma test measuring key biomarkers, enabling earlier, more accurate detection of...
- Likes
- 132
- Tags
- Research & Development, Healthcare Technology, Analytics & Insights
Showing 10 of 26 signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Danaher with the Signal API
One POST /v1/companies/enrich call with danaher.com returns Danaher signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "danaher.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Danaher other signals
What signals does Autobound track for Danaher besides news and filings?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .